Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hypocalcemia | 4 | 2021 | 120 | 3.08 | Why? |
| Adiposity | 3 | 2022 | 329 | 1.10 | Why? |
| Hypoparathyroidism | 1 | 2020 | 36 | 0.84 | Why? |
| Thoracic Vertebrae | 1 | 2021 | 97 | 0.82 | Why? |
| Obesity, Abdominal | 1 | 2021 | 167 | 0.78 | Why? |
| Spinal Fractures | 1 | 2021 | 124 | 0.77 | Why? |
| Calcium | 2 | 2020 | 708 | 0.73 | Why? |
| Overweight | 1 | 2021 | 916 | 0.56 | Why? |
| Weight Loss | 1 | 2020 | 826 | 0.56 | Why? |
| Malnutrition | 1 | 2020 | 932 | 0.43 | Why? |
| Hyperglycemia | 1 | 2022 | 1363 | 0.42 | Why? |
| Anthropometry | 2 | 2021 | 233 | 0.41 | Why? |
| Nutritional Status | 1 | 2020 | 1403 | 0.40 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.37 | Why? |
| Vitamin D Deficiency | 1 | 2022 | 1782 | 0.35 | Why? |
| Vitamin D | 1 | 2022 | 2904 | 0.31 | Why? |
| Pituitary Diseases | 1 | 2021 | 38 | 0.22 | Why? |
| Pituitary Gland | 1 | 2021 | 65 | 0.22 | Why? |
| Waist Circumference | 1 | 2021 | 199 | 0.21 | Why? |
| Osteoporosis, Postmenopausal | 1 | 2020 | 75 | 0.20 | Why? |
| Ileal Neoplasms | 1 | 2018 | 6 | 0.19 | Why? |
| Chromogranin A | 1 | 2018 | 15 | 0.19 | Why? |
| Intra-Abdominal Fat | 1 | 2021 | 227 | 0.18 | Why? |
| Italy | 5 | 2021 | 38444 | 0.16 | Why? |
| Osteoporosis | 1 | 2020 | 410 | 0.14 | Why? |
| Neuroendocrine Tumors | 1 | 2018 | 241 | 0.14 | Why? |
| Radiography, Thoracic | 2 | 2021 | 5486 | 0.13 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.13 | Why? |
| Prognosis | 5 | 2021 | 32490 | 0.11 | Why? |
| Pancreatic Neoplasms | 1 | 2018 | 609 | 0.11 | Why? |
| Blood Glucose | 2 | 2022 | 3642 | 0.10 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.10 | Why? |
| Biomarkers | 3 | 2022 | 23361 | 0.10 | Why? |
| Aged | 8 | 2022 | 215776 | 0.10 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.09 | Why? |
| Body Mass Index | 1 | 2022 | 4306 | 0.09 | Why? |
| Female | 10 | 2022 | 380317 | 0.09 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.09 | Why? |
| Male | 9 | 2022 | 367725 | 0.09 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.08 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.08 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.08 | Why? |
| Retrospective Studies | 3 | 2022 | 105322 | 0.07 | Why? |
| Middle Aged | 7 | 2022 | 270681 | 0.07 | Why? |
| Humans | 14 | 2022 | 930598 | 0.07 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.07 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.06 | Why? |
| Severity of Illness Index | 2 | 2022 | 48226 | 0.06 | Why? |
| Denosumab | 1 | 2020 | 49 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Risk Factors | 4 | 2022 | 71621 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.05 | Why? |
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2018 | 17 | 0.05 | Why? |
| Pericardium | 1 | 2021 | 228 | 0.05 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.05 | Why? |
| Somatostatin | 1 | 2018 | 49 | 0.05 | Why? |
| Octreotide | 1 | 2018 | 56 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| Proton Pump Inhibitors | 1 | 2018 | 377 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.02 | Why? |
| Adult | 2 | 2020 | 244371 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.01 | Why? |
Di Filippo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(86)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(80)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_